Pharma channel feed

Mer­ck­'s Keytru­da wins an­oth­er first — this time for an FDA nod to treat a sub­set of blad­der can­cer pa­tients

6 years ago
FDA+

Steep­est de­cline in US can­cer mor­tal­i­ty ever record­ed, study finds

6 years ago
R&D

Vas­cepa sparkle set to light up Amar­in's fourth quar­ter rev­enue

6 years ago

The list gets longer: Mer­ck, Al­ler­gan, No­var­tis is­sue 2020 drug price hikes — re­port

6 years ago

FDA of­fers As­traZeneca a short­cut on a land­mark SGLT2 ap­proval while Chi­na green­lights Lokel­ma

6 years ago
FDA+

BeiGene scores first Chi­na OK with PD-1 — to be man­u­fac­tured by Boehringer In­gel­heim

6 years ago
China

New year, new (high­er) drug prices

6 years ago

Here are the 52 new drugs ap­proved by the FDA in 2019. Who won? Who lost? And who just sur­vived to 2020?

6 years ago
Special

De­spite ques­tion­able PARP da­ta, FDA stamps quick OK on Lyn­parza as a front­line ther­a­py for pan­cre­at­ic can­cer

6 years ago

Amarin wins a block­buster ap­proval from the FDA. Now every­one can shift fo­cus to the patent

6 years ago
FDA+

A USP­TO le­gal ad­vis­er is off con­tro­ver­sial Gilead HIV case af­ter ac­tivists al­lege tweets show bias

6 years ago

Roche's triplet in­volv­ing Tecen­triq clears the PFS bar for melanoma when added to BRAF/MEK com­bo

6 years ago
R&D

House pass­es Pelosi drug pric­ing bill on par­ty-line vote

6 years ago

As­traZeneca joins Mer­ck, Bris­tol-My­ers in Chi­na's check­point race as reg­u­la­tors OK first PD-L1

6 years ago
China

Am­gen puts its foot down in shiny new South San Fran­cis­co hub as it re­or­ga­nizes R&D ops

6 years ago
R&D

Re­pub­li­cans un­veil a drug price bill to ri­val the De­moc­rats — promis­ing low­er prices and more cures

6 years ago

US biosim­i­lar launch­es about to turn a cor­ner

6 years ago

While No­var­tis com­bats gener­ic on­slaught in the courts, FDA ap­proves first Gilenya copy­cats

6 years ago
FDA+

In a win for in­dus­try, Trump ad­min­is­tra­tion is­sues scathing re­view of Pelosi drug pric­ing bill

6 years ago

Roche moves deep­er in­to Mer­ck ter­ri­to­ry with Tecen­triq/chemo OK in front­line NSCLC

6 years ago

Shak­ing up Chi­na's PD-(L)1 re­im­burse­ment land­scape, In­novent, Eli Lil­ly earn cov­et­ed spot on na­tion­al cov­er­age

6 years ago
China

J&J, Te­va and four oth­ers un­der crim­i­nal probe as feds in­ves­ti­gate opi­oid mak­ers for fail­ing to mon­i­tor dis­tri­b­u­tion

6 years ago

FDA ap­proves 5 new cost­ly drugs well ahead of PDU­FA dates

6 years ago
FDA+

Feds add fraud charges to the mul­ti­tude of ac­cu­sa­tions made against for­mer MiMedx ex­ecs

6 years ago
First page Previous page 258259260261262263264 Next page Last page
A service from the Financial Times